You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 7, July 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Controversies in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Neurology
 •Cerebrovascular Disease
 •Cardiovascular System
 •Evidence-Based Medicine
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sinus Thrombosis Should Be Treated With Anticoagulation

J. Stam, MD, PhD

Arch Neurol. 2008;65(7):984-985.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The treatment of cerebral venous sinus thrombosis (CVST) with heparin has been controversial for decades, but most experts now agree that most patients with CVST should receive rapid and full anticoagulation as soon as the diagnosis is made. Physicians who do not see many cases of CVST would be surprised to find out there is a dilemma at all. Treatment with anticoagulants for venous thrombosis in the legs and for pulmonary embolism is standard practice based on sound evidence. Adequately dosed heparin or, even better, full-dose low molecular weight preparations followed by some months of oral anticoagulants will prevent the extension of the thrombus and allow for natural recanalization. So why should CVST be an exception? The reason, of course, is the fear of cerebral hemorrhages. This concern is based on the fact that 30% to 40% of all patients with CVST have some degree of . . . [Full Text of this Article]

AUTHOR INFORMATION

Author Affiliation: Department of Neurology, University of Amsterdam, Amsterdam, the Netherlands.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Anticoagulation in Cerebral Venous Sinus Thrombosis: Are We Treating Ourselves?
Mohammad Wasay and Ayeesha Kamran Kamal
Arch Neurol. 2008;65(7):985-987.
EXTRACT | FULL TEXT  

Cerebral Venous Sinus Thrombosis: To Treat or Not to Treat?
E. S. Roach
Arch Neurol. 2008;65(7):987-988.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebral venous sinus thrombosis: a case series including thrombolysis
Mallick et al.
Arch. Dis. Child. 2009;94:790-794.
ABSTRACT | FULL TEXT  

Cerebral Venous Sinus Thrombosis: To Treat or Not to Treat?
Roach
Arch Neurol 2008;65:987-988.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.